2, 2% og 5, 0% (hazard rate 0, 43; 95% CI 0, 33- 0, 57) for fondaparinux og enoxaparin. e
In this subgroup, the incidence of major bleeding on fondaparinux and enoxaparin at Day 9 was 2.2% and 5.0% respectively (hazard ratio 0.43, 95% CI, 0.33; 0.57).